MedTrace Logo

Multi-Modality Echocardiographic Techniques in Pathological Left Ventricular Hypertrophy Adults

NCT05719337 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 660

Last updated 2023-02-10

No results posted yet for this study

Summary

This multicenter clinical study aims to evaluate the multi-modality echocardiographic parameters in patients with different pathological left ventricular hypertrophy (LVH) and investigate the correlation between echocardiographic parameters and different etiologies, providing an important theoretical basis for early identification and risk assessment in LVH patients.

Conditions

  • Left Ventricular Hypertrophy

Interventions

DEVICE

Echocardiography

Two-dimensional, color Doppler, spectral Doppler, tissue Doppler and three-dimensional echocardiographic image recordings will be taken using a Philips Epiq 7C echocardiography device and X5-1 probe. Conventional parameters, additional parameters, and strain analyzes will be performed by TomTec AutoStrain Suite Software.

Sponsors & Collaborators

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    collaborator OTHER

  • First Hospital of China Medical University

    lead OTHER

Principal Investigators

  • Chunyan Ma, Ph.D · the First Hospital of China Medical Univeristy

  • Li Zhang, Ph.D · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2024-08-05
Completion
2025-08-05

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05719337 on ClinicalTrials.gov